Insider · CIK 0001639860

Romano Steven J.

Reports to the SEC for 3 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001639860

Forms 4 and 5

Insider transactions

42 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-21	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+6,090 sh	—	—	6,090
2026-01-02	SLNSilence Therapeutics plc · Employee Share Option (Right to Buy)A Award	EVP and Chief R&D Officer	AAward	+300K sh	—	—	300,000
2025-05-22	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2025-01-02	SLNSilence Therapeutics plc · Employee Share Option (Right to Buy)A Award	EVP and Chief R&D Officer	AAward	+285K sh	—	—	285,000
2024-09-16	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000
2022-06-16	Keenova Therapeutics plcEmployee Share Options (Right to Buy)D Disposition to Issuer	EVP & Chief Sci. Ofcr	DDisposition to Issuer	−189K sh	—	—	0
2022-06-16	Keenova Therapeutics plcEmployee Share Options (Right to Buy)D Disposition to Issuer	EVP & Chief Sci. Ofcr	DDisposition to Issuer	−59.7K sh	—	—	0
2022-06-16	Keenova Therapeutics plcEmployee Share Options (Right to Buy)D Disposition to Issuer	EVP & Chief Sci. Ofcr	DDisposition to Issuer	−59.7K sh	—	—	0
2022-06-16	Keenova Therapeutics plcEmployee Share Options (Right to Buy)D Disposition to Issuer	EVP & Chief Sci. Ofcr	DDisposition to Issuer	−22.3K sh	—	—	0
2022-06-16	Keenova Therapeutics plcEmployee Share Options (Right to Buy)D Disposition to Issuer	EVP & Chief Sci. Ofcr	DDisposition to Issuer	−11.3K sh	—	—	0
2022-06-16	Keenova Therapeutics plcD Disposition to Issuer	EVP & Chief Sci. Ofcr	DDisposition to Issuer	−72.6K sh	—	—	0
2022-06-16	Keenova Therapeutics plcEmployee Share Options (Right to Buy)D Disposition to Issuer	EVP & Chief Sci. Ofcr	DDisposition to Issuer	−103K sh	—	—	0
2020-04-02	Keenova Therapeutics plcF Tax Payment	EVP & Chief Sci. Ofcr	FTax Payment	−3,022 sh	$1.80	−$5,439.6	72,637
2020-04-01	Keenova Therapeutics plcF Tax Payment	EVP & Chief Sci. Ofcr	FTax Payment	−1,924 sh	$1.93	−$3,713.32	75,659
2020-01-04	Keenova Therapeutics plcF Tax Payment	EVP & Chief Sci. Ofcr	FTax Payment	−284 sh	$3.26	−$925.84	77,583
2020-01-03	Keenova Therapeutics plcF Tax Payment	EVP & Chief Sci. Ofcr	FTax Payment	−883 sh	$3.36	−$2,966.88	77,867
2019-07-01	Keenova Therapeutics plcF Tax Payment	EVP & Chief Sci. Ofcr	FTax Payment	−285 sh	$9.09	−$2,590.65	78,245
2019-04-02	Keenova Therapeutics plcF Tax Payment	EVP & Chief Sci. Ofcr	FTax Payment	−3,103 sh	$22.80	−$70.7K	77,326
2019-04-01	Keenova Therapeutics plcEmployee Share Options (Right to Buy)A Award	EVP & Chief Sci. Ofcr	AAward	+103K sh	—	—	102,801
2019-04-01	Keenova Therapeutics plcA Award	EVP & Chief Sci. Ofcr	AAward	+22.5K sh	—	—	80,429
2019-01-04	Keenova Therapeutics plcF Tax Payment	EVP & Chief Sci. Ofcr	FTax Payment	−431 sh	$17.21	−$7,417.51	57,967
2019-01-03	Keenova Therapeutics plcF Tax Payment	EVP & Chief Sci. Ofcr	FTax Payment	−980 sh	$16.14	−$15.8K	58,398
2018-07-01	Keenova Therapeutics plcF Tax Payment	EVP & Chief Sci. Ofcr	FTax Payment	−285 sh	$18.66	−$5,318.1	59,378
2018-04-02	Keenova Therapeutics plcEmployee Share Options (Right to Buy)A Award	EVP & Chief Sci. Ofcr	AAward	+189K sh	—	—	189,201
2018-04-02	Keenova Therapeutics plcA Award	EVP & Chief Sci. Ofcr	AAward	+36.2K sh	—	—	59,663
2018-01-04	Keenova Therapeutics plcF Tax Payment	EVP & Chief Sci. Ofcr	FTax Payment	−507 sh	$23.40	−$11.9K	22,589
2018-01-03	Keenova Therapeutics plcF Tax Payment	EVP & Chief Sci. Ofcr	FTax Payment	−1,136 sh	$23.51	−$26.7K	23,096
2017-11-13	Keenova Therapeutics plcP Purchase	EVP & Chief Sci. Ofcr	PPurchase	+2,000 sh	$21.96	+$43.9K	24,232
2017-07-01	Keenova Therapeutics plcF Tax Payment	EVP & Chief Sci. Ofcr	FTax Payment	−310 sh	$44.81	−$13.9K	21,986
2017-06-09	Keenova Therapeutics plcP Purchase	EVP & Chief Sci. Ofcr	PPurchase	+1,000 sh	$39.88	+$39.9K	22,296
2017-02-10	Keenova Therapeutics plcP Purchase	EVP & Chief Sci. Ofcr	PPurchase	+1,000 sh	$49.68	+$49.7K	21,023
2017-01-03	Keenova Therapeutics plcA Award	EVP & Chief Sci. Ofcr	AAward	+10.6K sh	—	—	19,843
2017-01-03	Keenova Therapeutics plcEmployee Share Options (Right to Buy)A Award	EVP & Chief Sci. Ofcr	AAward	+59.7K sh	—	—	59,731
2017-01-03	Keenova Therapeutics plcEmployee Share Options (Right to Buy)A Award	EVP & Chief Sci. Ofcr	AAward	+59.7K sh	—	—	59,731
2016-07-01	Keenova Therapeutics plcF Tax Payment	EVP & Chief Sci. Ofcr	FTax Payment	−278 sh	$61.84	−$17.2K	9,013
2016-05-06	Keenova Therapeutics plcP Purchase	EVP & Chief Sci. Ofcr	PPurchase	+900 sh	$56.00	+$50.4K	9,291
2016-01-04	Keenova Therapeutics plcA Award	EVP & Chief Sci. Ofcr	AAward	+3,410 sh	—	—	7,436
2016-01-04	Keenova Therapeutics plcEmployee Share Options (Right to Buy)A Award	EVP & Chief Sci. Ofcr	AAward	+22.3K sh	—	—	22,288
2016-01-04	Keenova Therapeutics plcA Award	EVP & Chief Sci. Ofcr	AAward	+955 sh	—	—	8,391
2015-12-03	Keenova Therapeutics plcP Purchase	EVP & Chief Sci. Ofcr	PPurchase	+700 sh	$72.60	+$50.8K	4,026
2015-07-01	Keenova Therapeutics plcA Award	EVP & Chief Sci. Ofcr	AAward	+3,326 sh	—	—	3,326
2015-07-01	Keenova Therapeutics plcStock Options (Right to Buy)A Award	EVP & Chief Sci. Ofcr	AAward	+11.3K sh	—	—	11,275

Recent filings

Accepted (ET)
May 224
Romano Steven J.0001639860-26-000005
SEC(opens sec.gov)
Jan 64
Romano Steven J.0001639860-26-000002
SEC(opens sec.gov)
May 224
Romano Steven J.0000950170-25-076408
SEC(opens sec.gov)
Jan 64
Romano Steven J.0001415889-25-000745
SEC(opens sec.gov)
Sep 184
Romano Steven J.0000950170-24-107900
SEC(opens sec.gov)
Jun 214
Romano Steven J.0000899243-22-023426
SEC(opens sec.gov)
Apr 34
Romano Steven J.0000950138-20-000204
SEC(opens sec.gov)
Jan 74
Romano Steven J.0000950138-20-000017
SEC(opens sec.gov)
Jul 34
Romano Steven J.0000950138-19-000370
SEC(opens sec.gov)
Apr 34
Romano Steven J.0000950138-19-000221
SEC(opens sec.gov)

Companies

Address

C/O DIANTHUS THERAPEUTICS, INC. 7 TIMES SQUARE, 43RD FLOOR

NEW YORK, NY, 10036